BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rogers ME, Balistreri WF. Cascade of care for children and adolescents with chronic hepatitis C. World J Gastroenterol 2021; 27(12): 1117-1131 [PMID: 33828389 DOI: 10.3748/wjg.v27.i12.1117] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Pokorska-śpiewak M, Dobrzeniecka A, Ogrodnik A. Efficacy and Safety of the Treatment of Chronic Hepatitis C with Sofosbuvir/Ledipasvir in Children Aged 5 to 10 Years with Comorbidities—A Brief Report. Infectious Disease Reports 2022;14:574-8. [DOI: 10.3390/idr14040061] [Reference Citation Analysis]
2 Honegger JR, Gowda C. Defer no more: advances in the treatment and prevention of chronic hepatitis C virus infection in children. Curr Opin Infect Dis 2022. [PMID: 35852787 DOI: 10.1097/QCO.0000000000000856] [Reference Citation Analysis]
3 Bouare N, Keita M, Delwaide J. Comment on review article: Chronic hepatitis C virus infection cascade of care in pediatric patients. World J Gastroenterol 2022; 28(14): 1494-1498 [DOI: 10.3748/wjg.v28.i14.1494] [Reference Citation Analysis]
4 Bouare N, Keita M, Delwaide J. Comment on review article: Chronic hepatitis C virus infection cascade of care in pediatric patients. WJG 2022;28:1494-8. [DOI: 10.3748/wjg.v28.i14.1494] [Reference Citation Analysis]
5 Ades AE, Gordon F, Scott K, Collins IJ, Thorne C, Pembrey L, Chappell E, Mariné-Barjoan E, Butler K, Indolfi G, Gibb DM, Judd A. Spontaneous Clearance Of Vertically Acquired Hepatitis C Infection: Implications For Testing And Treatment. Clin Infect Dis 2022:ciac255. [PMID: 35396848 DOI: 10.1093/cid/ciac255] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Hozáková L, Vokatá B, Ruml T, Ulbrich P. Targeting the Virus Capsid as a Tool to Fight RNA Viruses. Viruses 2022;14:174. [DOI: 10.3390/v14020174] [Reference Citation Analysis]
7 Dong J, Wu T, Zhang Y, Xie Z, He J. Transcriptome and MicroRNAs Profiling Analysis of Huh7.5.1 Cells in Response to Hepatitis C Virus Infection. Hepat Mon 2021;21. [DOI: 10.5812/hepatmon.118724] [Reference Citation Analysis]
8 Pokorska-Śpiewak M, Dobrzeniecka A, Aniszewska M, Marczyńska M. Real-Life Experience with Ledipasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Virus Infection with Genotypes 1 and 4 in Children Aged 12 to 17 Years-Results of the POLAC Project. J Clin Med 2021;10:4176. [PMID: 34575286 DOI: 10.3390/jcm10184176] [Reference Citation Analysis]
9 Pokorska-Śpiewak M, Dobrzeniecka A, Marczyńska M. One-Year Outcomes after Ledipasvir/Sofosbuvir Treatment of Chronic Hepatitis C in Teenagers with and without Significant Liver Fibrosis-A Case Series Report. Viruses 2021;13:1518. [PMID: 34452383 DOI: 10.3390/v13081518] [Reference Citation Analysis]